ゴシポールの市場規模、シェア、成長分析：形態別、用途別、地域別 - 産業予測 2025～2032年

ゴシポール市場規模は2023年に376億3,000万米ドルとなり、予測期間（2025～2032年）のCAGRは9.8%で、2024年の413億2,000万米ドルから2032年には872億9,000万米ドルに成長する見通しです。

ゴシポール市場は、さまざまな用途、特にヒトと動物の避妊における需要の高まりによって成長を遂げています。HIV/AIDS、子宮・卵巣疾患、がんなどの治療における有効性が主張されていますが、これらの利点に対する科学的な裏付けはまだ限られています。綿実の有毒色素であるゴシポールは、Gossypium hirsutumとGossypium barbadenseの雑種に由来します。重要な商業製品であるゴシポールは、繊維産業にとって重要な天然繊維の供給源としての役割を果たすだけでなく、フィトアレキシンとして様々なセスキテルペノイドを提供しています。この2つの有用性は、特に従来にない健康治療への関心が高まる中、市場の可能性を強調しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格戦略分析
• ケーススタディ
• 規制情勢
• 特許分析

ゴシポール市場規模：形態別

• 市場概要
• 遊離型ゴシポール
• 結合型ゴシポール

ゴシポール市場規模：用途別

• 市場概要
• 男性用避妊薬
• 抗腫瘍薬
• 生理が重いまたは不規則
• 子宮筋腫
• 子宮内膜症
• その他

ゴシポール市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Nycomed（Switzerland）
• Shaanxi Panlong Pharmaceutical Group（China）
• Xi'an North Pharmaceutical（China）
• Harbin Sanlian Pharmaceutical（China）
• Sigma-Aldrich（United States）

結論と推奨事項

Gossypol Market size was valued at USD 37.63 billion in 2023 and is poised to grow from USD 41.32 billion in 2024 to USD 87.29 billion by 2032, growing at a CAGR of 9.8% during the forecast period (2025-2032).

The Gossypol market is experiencing growth due to rising demand across various applications, notably in birth control for both humans and animals. While there are claims regarding its efficacy in treating conditions such as HIV/AIDS, uterine and ovarian diseases, and cancer, scientific support for these benefits remains limited. Gossypol, a toxic pigment from cottonseed, is derived from hybrid species Gossypium hirsutum and Gossypium barbadense. As a significant commercial product, Gossypol not only serves as a vital source of natural fiber for the textile industry but also contributes various sesquiterpenoids as phytoalexins. This dual utility underscores the market's potential, particularly as interest in unconventional health treatments rises.

Top-down and bottom-up approaches were used to estimate and validate the size of the Gossypol market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Gossypol Market Segments Analysis

Global Gossypol Market is segmented by Form, Application and region. Based on Form, the market is segmented into Free Gossypol, and Bound Gossypol. Based on Application, the market is segmented into Male Birth Control Pill, Antitumor Drug, Heavy or Irregular Periods, Uterine Fibroids, Endometriosis and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Gossypol Market

The Gossypol market is significantly driven by its increasing applications in animal and human birth control. Known for its infertility-inducing properties, Gossypol effectively affects various animal species while demonstrating spermatogenesis inhibition in humans at lower doses. This naturally occurring polyphenol has been acknowledged for its potential in medicinal applications. Research indicates that oral Gossypol significantly reduces sperm count and functionality in an estimated 60% to 100% of men, with recovery rates varying post-treatment; between 50% to 77% may regain normal sperm levels within 3-24 months. However, about 10% of men experience persistently low sperm counts for over 4.5 years, further emphasizing its impact on reproductive health.

Restraints in the Gossypol Market

The Gossypol market is significantly influenced by supply limitations, predominantly due to China's dominance as the leading cotton producer, securing most patents related to Gossypol. As the world's largest grower of cotton, China consolidates a substantial portion of the Gossypol market, which is derived from the plant's seeds, roots, and stems. This concentration is expected to persist throughout the projected period. Nonetheless, regions such as North America and Europe are anticipated to experience considerable growth in Gossypol production and consumption over the forecast period, contributing to a more diversified market landscape moving forward.

Market Trends of the Gossypol Market

As of October 2023, the Gossypol market is experiencing notable advancements driven by its promising biological properties, particularly in antitumor and antiviral applications. Researchers are increasingly focused on enhancing the efficacy of gossypol through the development of modified derivatives that mitigate its inherent toxicity while amplifying therapeutic effects. This trend is fostering a surge in research and development investments in the pharmaceutical sector, aimed at leveraging gossypol's potential for treating various diseases. Consequently, the commercialization of gossypol-based therapies is anticipated to witness robust growth, positioning it as a key player in the biopharmaceutical landscape over the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Strategy Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Gossypol Market Size by Form & CAGR (2025-2032)

• Market Overview
• Free Gossypol
• Bound Gossypol

Global Gossypol Market Size by Application & CAGR (2025-2032)

• Market Overview
• Male Birth Control Pill
• Antitumor Drug
• Heavy or Irregular Periods
• Uterine Fibroids
• Endometriosis
• Other

Global Gossypol Market Size & CAGR (2025-2032)

• North America (Form, Application)
  • US
  • Canada
• Europe (Form, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Form, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Form, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Form, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Nycomed (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shaanxi Panlong Pharmaceutical Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xi'an North Pharmaceutical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Harbin Sanlian Pharmaceutical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations